Skip to main content
Boston Scientific’s family of CRT devices

Endoscopy

Our focus

We strive to be an industry leader in minimally invasive devices for diagnosing and treating gastrointestinal and pancreaticobiliary conditions.

Kyra’s story

This patient testimonial is sponsored by Boston Scientific. In a study, patients with class III obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of over 20% TBWL.

By combining a relentless dedication to developing an evolving portfolio of less-invasive technologies with a spirit of collaboration with healthcare professionals, we’re committed to improving patient care through continuous innovation, product development excellence and world-class support within the gastrointestinal and pancreaticobiliary spaces.

Delivering meaningful innovation

Supporting infection prevention.

The EXALT™ Model D Single-Use Duodenoscope is the first single-use duodenoscope, enabling physicians to complete endoscopic retrograde cholangiopancreatography (ERCP) procedures to diagnose and treat various pancreatic and biliary conditions. EXALT Model D was developed as an alternative to reusable duodenoscopes, eliminating the need for reprocessing and repairs, and allowing physicians to use a new, sterile device for every procedure.

Addressing outcomes.  

The SpyGlass™ DS Direct Visualization System, a single-use, single-operator digital cholangioscope, enables physicians to see high-resolution images from inside the biliary, hepatic and pancreatic ducts during ERCP. When used with the SpyBite™ Max Biopsy Forceps, physicians are enabled to take targeted biopsies of strictures to diagnose diseases such as cholangiocarcinoma or pancreatic cancer. When used with electrohydraulic lithotripsy (EHL) or laser lithotripsy, physicians have the tools to help them effectively and efficiently treat complex biliary stones.

Less-invasive treatment alternatives.

The AXIOS™ Stent and Electrocautery Enhanced Delivery System offers an endoscopic alternative for transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts and certain types of walled-off necrosis, as well as the gallbladder in patients with acute cholecystitis who are at high risk for surgery.*

Offering services and solutions.

Boston Scientific offers a range of healthcare services and solutions that are designed to help clinicians in their efforts to maintain costs, improve operational efficiencies and deliver high-quality patient care. We offer a range of infection prevention products and solutions for use in the endoscopy suite.

check icon

Since 2016, the SpyGlass™ Direct Visualization System has impacted nearly 200K patients across the globe.1

check icon

Worldwide, over 150K procedures have utilized the AXIOS™ Stent and Electrocautery Enhanced Delivery System.2

check icon

The EXALT™ Model D is the only single-use duodenoscope with 7 peer-reviewed, published studies, involving more than 1,000 patients across all ERCP complexity grades.3,4,5,6,7,8,9


Conditions our customers treat with Boston Scientific products

  • Malignant and Benign Tumors
  • Gastrointestinal Cancers & Diseases
  • Pancreaticobiliary Stones
  • Pulmonary Diseases & Lung Cancer
  • Obesity
  • Upper and Lower Gastrointestinal Bleeding
  • Pancreatitis

4th

leading cause of cancer death in the U.S.: pancreatic.10

1 in every 3

cancer-related deaths worldwide: gastrointestinal.11

10%

mortality rate with upper gastrointestinal bleeds.12

~ 650M

adults worldwide are obese.13


Products and solutions we offer

  • Biliary Access
  • Biliary Stricture and Stone Management
  • Biopsy
  • Dilation
  • Endoscopic Ultrasound (EUS)
  • Hemostasis
  • Airway
  • Cholangioscopy
  • Stents: Enteral & Esophageal
  • Tissue Resection
  • Endoscopic Mucosal Resection
  • Enteral feeding
  • Radiofrequency ablation
  • Infection prevention
  • Single-use imaging
  • Single-use scopes

Product spotlights

* U.S. Gallbladder indication is for 10mm×10mm and 15mm×10mm stents only. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

  1. As of February 2024. Based on Boston Scientific sales data for the SpyGlass™ DS Direct Visualization System and the SpyGlass™ DS II Direct Visualization System. 
  2. As of EOY 2023. Based on Boston Scientific sales data.
  3. Bang et al. Equivalent performance of single-use and reusable duodenoscopes in a randomized trial. Gut 2020;0:1-7.
  4. Muthusamy et al. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Clinical Gastroenterology and Hepatology 2020:1-10.
  5. Napolean et al. Evaluation of the performance of a single-use duodenoscope: Prospective multi-center national study, Digestive Endoscopy 2021:1-7.
  6. Slivka A et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021 Jun 26:S0016-5107(21)01464-4. doi: 10.1016/j.gie.2021.06.017. Epub ahead of print. PMID: 34186052.
  7. Shahid et al. Comparing the Safety and Efficacy of Two Commercially Available Single-Use Duodenoscopes. 2022 Aug 24. doi: 10.1097/MCG.0000000000001752.
  8. D. Persyn et al. Performance and applicability of a first generation single-use duodenoscope: a single-center cohort study. Annals of Gastroenterology (2022) 35, 368-375.
  9. Bruno MJ, et al. Global prospective case series of ERCPs using a single-use duodenoscope. Endoscopy. 2023 Dec;55(12):1103-1114. Sponsored in part by Boston Scientific.
  10. American Cancer Society. Cancer Facts & Figures 2023. Atlanta: American Cancer Society; 2023, Page 10
  11. “Global Burden of Gastrointestinal Cancers.” World Health Organization, World Health Organization, gco.iarc.who.int/stories/gastro-intestinal/en. Accessed 2024.
  12. DiGregorio AM, Alvey H. Gastrointestinal Bleeding. Treasure Island, FL: StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537291/
  13. World Health Organization. World Obesity Day 2022 – Accelerating action to stop obesity. Geneva, Switzerland: WHO; 2022 March.

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a physician.

Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. All trademarks are the property of their respective owners.